Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1796048

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1796048

Venous Thromboembolism Treatment

PUBLISHED:
PAGES: 384 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Venous Thromboembolism Treatment Market to Reach US$2.8 Billion by 2030

The global market for Venous Thromboembolism Treatment estimated at US$2.2 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Non-Segmented Pneumatic Compression Pumps, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$826.2 Million by the end of the analysis period. Growth in the Segmented Pneumatic Compression Pumps without Gradient segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$610.6 Million While China is Forecast to Grow at 7.2% CAGR

The Venous Thromboembolism Treatment market in the U.S. is estimated at US$610.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$570.3 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Venous Thromboembolism Treatment Market - Key Trends & Drivers Summarized

What Is Causing A Surge In Therapeutic Innovation Around VTE Management?

Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), continues to present a substantial clinical challenge due to its prevalence, recurrence risk, and potentially fatal outcomes. The condition affects nearly 10 million people annually worldwide, with mortality often resulting from undiagnosed or undertreated PE. Over the past decade, therapeutic protocols have undergone significant change, propelled by an evolution in pharmacological agents, diagnostic accuracy, and interventional strategies. The shift away from warfarin toward direct oral anticoagulants (DOACs) has been particularly influential, offering patients fixed dosing, fewer dietary restrictions, and reduced need for monitoring.

Regulatory approvals of DOACs such as rivaroxaban, apixaban, and edoxaban have redefined first-line treatment pathways. These agents are now widely recommended in guidelines by ACCP, ESC, and NICE for both acute and extended VTE management. Simultaneously, there has been a growing emphasis on individualized treatment regimens based on bleeding risk, renal function, and cancer co-morbidities. Novel agents targeting Factor XIa and tissue factor pathway inhibitors are in late-stage clinical trials, offering the potential to reduce thrombotic risk with minimal bleeding liability. This next wave of anticoagulants aims to bridge the gap between efficacy and safety in high-risk populations.

How Are Interventional and Supportive Approaches Reshaping the VTE Treatment Landscape?

Beyond anticoagulant pharmacotherapy, the treatment of VTE is increasingly incorporating endovascular techniques, particularly for severe or recurrent cases. Catheter-directed thrombolysis (CDT), pharmacomechanical thrombectomy, and balloon angioplasty are now considered in select patients with iliofemoral DVT or life-threatening PE. These interventions aim to restore venous patency, reduce post-thrombotic syndrome, and prevent chronic thromboembolic pulmonary hypertension (CTEPH). Integration of intravascular ultrasound (IVUS), clot fragmentation technologies, and real-time perfusion imaging is improving procedural precision, expanding eligibility among patients previously deemed unsuitable for invasive treatment.

In parallel, mechanical prophylactic tools such as intermittent pneumatic compression (IPC) devices, graduated compression stockings, and inferior vena cava (IVC) filters remain essential adjuncts in surgical wards, ICU settings, and trauma centers. Advanced analytics and predictive algorithms are being embedded into electronic health records (EHRs) to identify patients at highest VTE risk and trigger preventative measures. Wearable biosensors and AI-driven platforms are also emerging, helping monitor adherence and coagulation markers in outpatient settings, thereby facilitating remote VTE management and relapse prevention.

Where Is Demand for VTE Therapies Rising, and Which Patient Populations Are Driving It?

The demand for VTE treatment is increasing globally, but especially in aging societies with high surgical and cancer burdens. The United States and Europe lead in terms of treatment volumes, supported by structured VTE prevention programs in hospitals, widespread availability of DOACs, and a growing number of interventional radiologists trained in clot removal techniques. In Asia-Pacific, however, the market is rapidly catching up, driven by improving diagnostic infrastructure and expanded health insurance coverage for anticoagulants and diagnostic imaging modalities like duplex ultrasound and CT angiography.

High-risk groups fueling the VTE treatment market include post-operative orthopedic patients, cancer patients undergoing chemotherapy, pregnant women, and individuals with genetic clotting disorders such as Factor V Leiden. Notably, oncology patients represent a major focus area as cancer-associated thrombosis has emerged as a significant contributor to morbidity. Pharma companies are tailoring studies to evaluate VTE outcomes in this cohort, while hospitals are implementing risk-adjusted prophylaxis protocols in oncology wards. The pandemic-induced rise in thrombotic complications among hospitalized COVID-19 patients has also intensified focus on early detection and intervention in inflammatory and critical care settings.

What Forces Are Powering Growth in the Global VTE Treatment Market?

The growth in the venous thromboembolism treatment market is driven by several factors, including the shift toward DOAC-based management, rising surgical interventions, and expanding awareness among both physicians and patients. Healthcare systems are investing in early detection protocols to reduce VTE-related readmissions and fatalities. National policies-such as NHS England’s Commissioning for Quality and Innovation (CQUIN) framework and U.S. CMS mandates-are reinforcing systematic VTE risk assessments and preventive action plans in clinical settings.

Pharmaceutical pipeline activity is robust, with multiple late-stage anticoagulant candidates showing promise for reducing bleeding complications. Market players are also investing in co-packaging solutions and fixed-dose combinations to improve adherence. On the device side, thrombectomy platforms and compression systems are benefiting from increased procedural volume in tertiary care and ambulatory surgery centers. Public health education and DTC campaigns are further amplifying treatment-seeking behavior. Collectively, these dynamics point to a sustained and diversified expansion of the global VTE treatment market across drugs, devices, and digital platforms.

SCOPE OF STUDY:

The report analyzes the Venous Thromboembolism Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Other Products); Indication (Deep Venous Thrombosis Indication, Pulmonary Embolism Indication); End-User (Hospitals End-User, Catheterization Laboratories End-User, Ambulatory Surgery Centers End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Alexion (AstraZeneca Rare Disease)
  • AngioDynamics
  • Aspen Pharmacare
  • AstraZeneca
  • Bayer AG
  • Bayer AG (vascular devices division)
  • Bristol-Myers Squibb
  • Cipla Inc.
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Eli Lilly and Co.
  • GlaxoSmithKline
  • Hikma Pharmaceuticals
  • Inari Medical
  • Johnson & Johnson
  • Merck & Co.
  • Mylan (now part of Viatris)
  • Novartis AG
  • Pfizer Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP39483

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Venous Thromboembolism Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Deep Vein Thrombosis and Pulmonary Embolism Throws the Spotlight on Venous Thromboembolism Treatment
    • Growing Awareness of Post-Surgical and Cancer-Related VTE Risk Spurs Adoption of Prophylactic Therapies
    • Expansion of Direct Oral Anticoagulants (DOACs) Portfolio Strengthens the Business Case for Non-Vitamin K Antagonist Treatments
    • Post-COVID Complications and Immobility-Related Clot Risks Accelerate Demand for Effective VTE Therapies
    • Rising Preference for Targeted Mechanical and Catheter-Directed Thrombolysis Expands Market for Interventional Devices
    • Increased Use of Compression Therapy and Risk Stratification Tools Supports Early VTE Prevention and Treatment
    • Growth in Aging Population and Sedentary Lifestyles Fuels Demand for Long-Term VTE Management Solutions
    • Technological Advancements in Imaging and DVT Diagnostics Enable Timely and Accurate Therapeutic Intervention
    • Integration of VTE Treatment Pathways in Oncology and Cardiology Supports Cross-Specialty Therapy Uptake
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Venous Thromboembolism Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Venous Thromboembolism Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Venous Thromboembolism Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Non-Segmented Pneumatic Compression Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Non-Segmented Pneumatic Compression Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Non-Segmented Pneumatic Compression Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Segmented Pneumatic Compression Pumps without Gradient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Segmented Pneumatic Compression Pumps without Gradient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Segmented Pneumatic Compression Pumps without Gradient by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Segmented Pneumatic Compression Pumps with Calibrated Gradient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Segmented Pneumatic Compression Pumps with Calibrated Gradient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Segmented Pneumatic Compression Pumps with Calibrated Gradient by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Upper Pneumatic Compression Sleeves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Upper Pneumatic Compression Sleeves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Upper Pneumatic Compression Sleeves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Lower Pneumatic Compression Sleeves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Lower Pneumatic Compression Sleeves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Lower Pneumatic Compression Sleeves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Permanent Inferior Vena Cava Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Permanent Inferior Vena Cava Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Permanent Inferior Vena Cava Filters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Catheterization Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Catheterization Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Catheterization Laboratories End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Deep Venous Thrombosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Deep Venous Thrombosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Deep Venous Thrombosis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pulmonary Embolism Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pulmonary Embolism Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Pulmonary Embolism Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • JAPAN
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • CHINA
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • EUROPE
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Venous Thromboembolism Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Venous Thromboembolism Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • FRANCE
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • GERMANY
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Venous Thromboembolism Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Venous Thromboembolism Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • INDIA
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Venous Thromboembolism Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Venous Thromboembolism Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Venous Thromboembolism Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Venous Thromboembolism Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030
  • AFRICA
    • Venous Thromboembolism Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Venous Thromboembolism Treatment by Product - Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Venous Thromboembolism Treatment by Product - Percentage Breakdown of Value Sales for Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Venous Thromboembolism Treatment by End-user - Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Venous Thromboembolism Treatment by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Catheterization Laboratories End-User and Ambulatory Surgery Centers End-User for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Venous Thromboembolism Treatment by Indication - Deep Venous Thrombosis Indication and Pulmonary Embolism Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Venous Thromboembolism Treatment by Indication - Percentage Breakdown of Value Sales for Deep Venous Thrombosis Indication and Pulmonary Embolism Indication for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!